908 Devices (MASS) Net Income Growth (1y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -11.74% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4,440.69% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 89.28% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -30.10% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | 908 Devices | 314.43 Mn | 202.69 Mn | 6.88 Mn | -122.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -122.36% |
| Dec 31, 2025 | 94.04% |
| Sep 30, 2025 | 98.72% |
| Jun 30, 2025 | 92.00% |
| Mar 31, 2025 | 1,164.12% |
| Dec 31, 2024 | 53.94% |
| Sep 30, 2024 | 20.39% |
| Jun 30, 2024 | 46.77% |
| Mar 31, 2024 | 59.93% |
| Dec 31, 2023 | 24.12% |
| Sep 30, 2023 | -13.32% |
| Jun 30, 2023 | -15.40% |
| Mar 31, 2023 | -33.75% |
| Dec 31, 2022 | -174.41% |
| Sep 30, 2022 | -17.94% |
| Jun 30, 2022 | -8.07% |
| Mar 31, 2022 | -51.47% |
| Dec 31, 2021 | 13.61% |
| Sep 30, 2021 | -245.06% |
| Jun 30, 2021 | -498.19% |
| Mar 31, 2021 | -105.86% |